The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: oxaliplatin     Quarter: 2016Q3

Total Records: 864     Number of Pages: 44

DRUGNAME PT EventCount
OXALIPLATIN. Supraventricular extrasystoles 8
OXALIPLATIN. Therapeutic response decreased 8
Oxaliplatin Hospira Paraesthesia 7
OXALIPLATIN. Aspartate aminotransferase increased 7
OXALIPLATIN. Capillary leak syndrome 7
OXALIPLATIN. Deep vein thrombosis 7
OXALIPLATIN. Haematotoxicity 7
OXALIPLATIN. Hepatic failure 7
OXALIPLATIN. Infection 7
OXALIPLATIN. Loss of consciousness 7
OXALIPLATIN. Malignant neoplasm progression 7
OXALIPLATIN. Pneumonitis 7
OXALIPLATIN. Protein urine 7
OXALIPLATIN. Syncope 7
OXALIPLATIN. Throat irritation 7
OXALIPLATINE Loss of consciousness 7
OXALIPLATIN 5mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION Nausea 6
Oxaliplatin Hospira Aphasia 6
Oxaliplatin Hospira Disorganised speech 6
Oxaliplatin Hospira Gait disturbance 6

Total Records: 864     Number of Pages: 44